Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion options in total joint arthroplasty.

E Michael Keating1, Merrill A Ritter

  • 1Center for Hip and Knee Surgery, St. Francis Hospital-Mooresville, Mooresville, Indiana 46158 , USA.

The Journal of Arthroplasty
|June 18, 2002
PubMed
Summary

Erythropoietin alfa is the most effective method to reduce allogeneic blood transfusion risks in joint arthroplasty patients with mild anemia. Patients with normal hemoglobin levels have minimal transfusion risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examination of the Acutely Injured Knee.

The Physician and sportsmedicine·2017
Same author

Mechanical Strength of the Proximal Tibia Following Total Knee Arthroplasty: A Cadaveric Study of Resection Depth and Bone Density.

Surgical technology international·2017
Same author

Seasonal variation in adult hip disease secondary to osteoarthritis and developmental dysplasia of the hip.

World journal of orthopedics·2016
Same author

Clinical predictors for possible failure after total hip arthroplasty.

Hip international : the journal of clinical and experimental research on hip pathology and therapy·2016
Same author

ACL Damage and Deficiency is Associated with More Severe Preoperative Deformity, Lower Range of Motion at the Time of TKA.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery·2016
Same author

Twenty-Five-Years and Greater, Results After Nonmodular Cemented Total Knee Arthroplasty.

The Journal of arthroplasty·2016

Area of Science:

  • Orthopedic Surgery
  • Transfusion Medicine
  • Anemia Management

Background:

  • Allogeneic blood transfusions carry risks like viral infection and immunosuppression.
  • Alternative transfusion strategies are explored for total joint arthroplasty (TJA).
  • Previous methods like blood salvage and autologous donation show limited efficacy in TJA.

Purpose of the Study:

  • To evaluate the efficacy of epoetin alfa in reducing allogeneic blood transfusion risks in TJA patients.
  • To identify optimal transfusion strategies based on preoperative hemoglobin levels.

Main Methods:

  • Analysis of transfusion rates and risks associated with various methods.
  • Focus on patients undergoing total knee and total hip arthroplasty.
  • Comparison of epoetin alfa with other transfusion alternatives.

Related Experiment Videos

Main Results:

  • Intraoperative/postoperative blood salvage is not cost-effective except in revision hip arthroplasty.
  • Autologous donation is ineffective.
  • Epoetin alfa effectively decreases allogeneic risk to 12.9% in anemic patients (hemoglobin 10-13 g/dL).
  • Patients with preoperative hemoglobin >14 g/dL have minimal allogeneic risk.

Conclusions:

  • Epoetin alfa is the most efficient strategy to mitigate allogeneic transfusion risks in TJA patients with preoperative anemia.
  • Patients with normal preoperative hemoglobin levels do not require intervention to minimize transfusion risks.